Chorionic Gonadotrophin for injection

Short Description:


1. Diagnosis and treatment of prepubertal cryptorchidism.

2. Male infertility caused by hypopituitarism can be combined with urogonadotropin. Long-term hypogonadotropin function. It should also be supplemented with testosterone therapy.

3. Anovulatory infertility in women caused by pituitary gonadotropin insufficiency is often combined with urogonadotrophin to promote ovulation after clomiphene treatment is ineffective.

4. Used for in vitro fertilization to obtain multiple oocytes, in combination with menotrophin.

5. Treatment of luteal insufficiency in women.

6. Functional uterine bleeding, threatened miscarriage in the first trimester, recurrent miscarriage.

Product Detail

Product Tags


Chorionic Gonadotrophin for injection


Pregnant woman urine


This product is a freeze-dried sterile product with chorionic gonadotrophin plus suitable excipients. Its titer should be 80%~125% of the labeled amount Chorionic Gonadotrophin for Injection is a sterile material consisting of Chorionic Gonadotrophin with or without excipients. It is supplied in a sealedcontainer

Pharmacopoeia standard




This product is a white lyophilized block or powder. A white or almost white, amorphous powder


_______ Causes an increase in the weight of the seminal vesicles or the prostate glands of immature male rats when administered as directed under the Assay.


Loss on drying ≤5.0% _______
Abnormal toxicity Conform with regulation
Bacterial endotoxin ≤0.01EU/IU The endotoxin limit concentration of solution A is 15 IU of endotoxin per mL
Acidity or alkalinity _______ pH of a 1% w/v solution, 6.0 to 8.0
Clarity and colour of solution _______ Solution is clear and colourless
Content uniformity ±15% _______
Visible foreign matter Conform with regulation _______
Sterile Conform with regulation _______


80%~125% of the stated potency 80%~125% of the stated potency


Sealed and kept in a cool dark place. The sealed container should be protected from light and stored at a temperature not exceeding 20℃.


Gonadotropin drugs


1000 units      5000units

1000 units   5000units


Patients suspected of having pituitary hyperplasia or swelling and pain, prostate cancer or other androgen-related swelling and pain tumors are contraindicated (with promoting effect). Patients with precocious puberty, vaginal bleeding with an undiagnosed diagnosis, subordinate fibroids, ovarian cysts or ovarian enlargement, thrombophlebitis, and patients with a history of allergy to gonadal stimulating hormones are contraindicated.


1. It should be used with caution in the following conditions: enlarged prostate, asthma, epilepsy, heart disease, migraine, renal impairment, etc.
2. If ovarian hyperstimulation syndrome and ovarian enlargement, pleural effusion, ascites and other comorbidities are found, the drug should be discontinued or seek medical advice.
3. The possibility of multiple pregnancies should be communicated to the patient before use. Ask about adverse reactions during use and conduct relevant clinical examinations regularly.
4. Pregnancy tests can be falsely positive and should be tested 10 days after administration.
5. Use with caution in patients with hypertension.
6. This product is temporarily formulated before application.

  • Previous:
  • Next:

  • Write your message here and send it to us